Keywords: ell Therapeuticcs, Pixuvri, Europe, Financial results, Pacritinib, Tosedostat

Cell Therapeutics prepares for Pixuvri launch; posts 2nd-qtr results

Article | 01 August 2012

US biotech firm Cell Therapeutics (Nasdaq: CTIC) yesterday reported second-quarter 2012 financial results and recent accomplishments, including plans for the launch ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Cell Therapeutics

Go to company listing

Related Drugs

Pixuvri

pacritinib

tosedostat

Go to drug listing